Still Pipette-Filling Cryovials? There's A Better Way

If you're still relying on manual pipetting to fill cryovials for cell and gene therapy, you might be unknowingly hurting your product's quality and your process's scalability. This time-consuming, error-prone method ties up skilled technicians and creates major risks, from uneven cell volumes to potential contamination. With increasing pressure to cut costs and meet strict regulations, manual methods are no longer sustainable. There’s a pressing need for a more reliable and scalable solution to ensure precision and preserve delicate cell integrity. Discover how automating this crucial step can revolutionize your manufacturing process and improve patient outcomes. Read on to learn more.